Defining success in heart failure: the end-point mess.
Explore this paper's citation graph
Summary
Since those heady times, the evolution of therapy for heart failure has become increasingly complex and the managing clinician must integrate a number of factors about the individual heart failure patient before adding treatments to the pharmacological foundation of renin-angiotensin and β-adrenergic inhibition.
- Type
- letter
- Published
- 2010-05-11
- Cited by
- 11
- References
- 28
- Access
- Open access
- OpenAlex
- https://openalex.org/W2013532853
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:33446078
Keywords
Heart failure, Medicine, Enalapril, Clinical endpoint, Clinical trial
References
- Recent National Trends in Readmission Rates after Heart Failure Hospitalization
- Agreement is Poor Amongst Current Criteria Used to Define Response to Cardiac Resynchronization Therapy
- Long-term use of a left ventricular assist device for end-stage heart failure.
- Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).
- Phase III clinical trial end points in acute heart failure syndromes: a virtual roundtable with the Acute Heart Failure Syndromes International Working Group.
- Relation between dose of loop diuretics and outcomes in a heart failure population: Results of the ESCAPE Trial
- Association of Weight Change With Subsequent Outcomes in Patients Hospitalized with Acute Decompensated Heart Failure
- The effect of cardiac resynchronization on morbidity and mortality in heart failure.
- Choice of clinical outcomes in randomized trials of heart failure therapies: disease-specific or overall outcomes?
- Second Intermacs Annual Report: More Than 1000 Primary LVAD Implants
- INTERMACS profiles of advanced heart failure: the current picture.
- Six minute corridor walk test as an outcome measure for the assessment of treatment in randomized, blinded intervention trials of chronic heart failure: a systematic review.
- Cardiac-resynchronization therapy for the prevention of heart-failure events.
- Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure
- Advanced heart failure treated with continuous-flow left ventricular assist device.
- Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial.
- Public reporting of discharge planning and rates of readmissions.
- Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.
- Definitions for Acute Coronary Heart Disease in Epidemiology and Clinical Research Studies
Cited by
- Effect of Admission Oral Diuretic Dose on Response to Continuous versus Bolus Intravenous Diuretics in Acute Heart Failure: An Analysis from DOSE-AHF
- Endothelial dysfunction, arterial stiffness, and heart failure.
- End-point selection for acute heart failure trials.
- Response to Coceani: Cardiac resynchronization therapy has earned its class I recommendation and continues to thrive under scrutiny.
- EFFECT OF ADMISSION ORAL DIURETIC DOSE ON RESPONSE TO CONTINUOUS VERSUS BOLUS INTRAVENOUS DIURETICS IN ACUTE HEART FAILURE: AN ANALYSIS FROM DOSE-AHF
- Phase II trials in heart failure: The role of cardiovascular imaging
- Mariell Jessup: Shaping a Subspecialty.
- Sex-specific Evaluation of Ventricular Ejection Fraction and End-Systolic Volume Applied to Cardiac Resynchronization Therapy
- Challenges for the Basis of Practice Response to Coceani: Cardiac Resynchronization Therapy Has Earned Its Class I Recommendation and Continues to Thrive Under Scrutiny
- Evaluation of Heart Failure Symptoms for Device Therapy
- Heart Failure (or Congestive Heart Failure)
- The Challenge of Optimal Heart Failure Management: Present and Future
Related papers
- Effects of enalapril on long-term mortality in severe congestive heart failure. CONSENSUS Trial Group.
- Effect of Enalapril on Mortality in Congestive Heart Failure
- Enalapril in heart failure.
- The influence of dietary peptide inhibitors of angiotensin-converting enzyme on the hypotensive effects of enalapril
- Enalapril in the long-term treatment of elderly hypertensives.
- Attenuation of left ventricular dilatation after acute myocardial infarction by early initiation of enalapril therapy. CONSENSUS II Multi-Echo Study Group.
- Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.
- Results of the veterinary enalapril trial to prove reduction in onset of heart failure in dogs chronically treated with enalapril alone for compensated, naturally occurring mitral valve insufficiency.
- Clinical and prognostic implications of heart failure hospitalization in patients with advanced heart failure